- Reference code :
- wf3503
- Published date :
-
21 October 2004
- Expired date :
-
08 March 2032
“A strong third quarter with sales up 7 percent and Earnings per Share up 19 percent.”
AstraZeneca PLC
Third Quarter and Nine Months Results 2004
Download the narrative and the figures .
Media Enquiries:
Steve Brown/Edel McCaffrey (London) (020) 7304 5033/5034
Staffan Ternby (Södertälje) (8) 553 26107
Rachel Bloom-Baglin (Wilmington) (302) 886 7858
Analyst/Investor Enquiries:
Mina Blair/Jonathan Hunt (London) (020) 7304 5084/5087
Staffan Ternby (Södertälje) (8) 553 26107
Ed Seage/Jörgen Winroth (US) (302) 886 4065/(212) 579 0506
Third Quarter and Nine Months Results 2004
Download the narrative and the figures .Further enquiries to:
Media Enquiries:
Steve Brown/Edel McCaffrey (London) (020) 7304 5033/5034
Staffan Ternby (Södertälje) (8) 553 26107
Rachel Bloom-Baglin (Wilmington) (302) 886 7858
Analyst/Investor Enquiries:
Mina Blair/Jonathan Hunt (London) (020) 7304 5084/5087
Staffan Ternby (Södertälje) (8) 553 26107
Ed Seage/Jörgen Winroth (US) (302) 886 4065/(212) 579 0506
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 10:09 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
